MedPath

NEUROVERSION, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Effect of Stellate Ganglion Block on ME/CFS

Phase 1
Completed
Conditions
Encephalomyelitis, Myalgic
Chronic Fatigue Syndrome
Chronic Fatigue Disorder
Chronic Fatigue and Immune Dysfunction Syndrome
Myalgic Encephalomyelitis
Postviral Fatigue Syndrome
Systemic Exertion Intolerance Disease
Infectious Mononucleosis-Like Syndrome, Chronic
Chronic Fatigue-Fibromyalgia Syndrome
Interventions
First Posted Date
2022-12-27
Last Posted Date
2024-12-06
Lead Sponsor
Neuroversion, Inc.
Target Recruit Count
10
Registration Number
NCT05664711
Locations
🇺🇸

Neuroversion, Anchorage, Alaska, United States

© Copyright 2025. All Rights Reserved by MedPath